Table 4.
DAS28 | CPDAI | PASDAS | GRACE | DAPSA | |
---|---|---|---|---|---|
Much improved (n = 39) | 1.42 (1.12, 1.73) | 1.87 (1.31, 2.43) | 1.86 (1.51, 2.21) | 1.78 (1.42, 2.14) | 13 (10.3, 15.8) |
Somewhat improved (n = 78) | 0.69 (0.51, 0.86) | 1.54 (1.12, 1.96) | 1.06 (0.86, 1.26) | 0.97 (0.74, 1.2) | 5.8 (3.7, 7.9) |
Stable (n = 100) | 0.22 (0.07, 0.36) | 0.27 (−0.03, 0.57) | 0.36 (0.2, 0.52) | 0.34 (0.19, 0.48) | 3 (1.6, 4.4) |
Somewhat worsened (n = 41) | −0.01 (−0.28, 0.27) | 0.02 (−0.52, 0.57) | −0.09 (−0.37, 0.2) | −0.22 (−0.53, 0.08) | 0.1 (−2.5, 2.7) |
Much worsened (n = 7) | −0.25 (−1.24, 0.75) | 0 (−1.51, 1.51) | −0.69 (−1.41, 0.03) | −1.28 (−2.16, −0.4) | −4.8 (−10, 0.5) |
Results shown as mean (95% CI). CPDAI: Composite Psoriatic Disease Activity Index; DAPSA: Disease Activity index for PSoriatic Arthritis; DAS28: Disease Activity Score 28; GRACE: GRAppa Composite ScorE; PASDAS: Psoriatic ArthritiS Disease Activity Score.